v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 65,442 $ 66,479
Restricted cash 14,595 15,247
Accounts receivable, less allowances of $2,680 and $2,416, respectively 280,393 250,717
Inventories 349,354 348,226
Prepaid expenses and other current assets 35,018 31,505
Total current assets 744,802 712,174
Property, plant and equipment, net 125,874 125,524
Rental equipment, net 38,105 39,376
Goodwill 464,098 462,789
Deferred tax asset, net 128 136
Intangible assets, net 258,680 269,763
Cash value of life insurance 19,726 19,916
Right of use operating lease assets 106,468 91,962
Other assets 5,031 5,615
Total assets 1,762,912 1,727,255
Current liabilities:    
Accounts payable 134,206 125,575
Current portion of long-term debt 40,740 40,476
Current portion of lease liabilities 18,664 18,951
Accrued expenses and other current liabilities 78,628 81,259
Total current liabilities 272,238 266,261
Long-term debt, less current portion, net 712,370 693,903
Lease liabilities 94,057 77,758
Deferred tax liability, net 22,734 22,265
Other liabilities 24,800 26,525
Total liabilities 1,126,199 1,086,712
Commitments and contingencies (Note 15)
Stockholders’ equity:    
Preferred stock, $1 par value: Authorized - 500,000 shares, issued and outstanding — None 0 0
Common stock, $1 par value: Authorized - 70,000,000 shares Issued - 47,770,100 and 47,738,290 shares, respectively Outstanding - 46,567,929 and 46,856,757 shares, respectively 46,567 46,856
Capital in excess of par value 680,210 677,473
Retained deficit (38,778) (42,039)
Treasury stock – 1,202,171 and 881,533 shares, respectively (30,834) (19,631)
Accumulated other comprehensive income (loss) (20,452) (22,116)
Total stockholders’ equity 636,713 640,543
Total liabilities and stockholders’ equity $ 1,762,912 $ 1,727,255